Efficacy and Safety of Allergen-Specific Immunotherapy in Rhinitis, Rhinoconjunctivitis, and Bee/Wasp Venom Allergies

REFERENCES

• W.F. Schoenwetter, L. Dupclay, Jr., S. Appajosyula, M.F. Botteman, and C.L. Pashos, Economic impact and quality-of-life burden of allergic rhinitis, Curr. Med. Res. Opin., 20: 305–317, 2004. [CSA]
   PubMed Web of Science ®Google Scholar
• S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, W. Noble, S.J. Till, Q.A. Hamid, and K.T. Nouri-Aria, Long-term clinical efficacy of grass-pollen immunotherapy, N. Engl. J. Med., 341: 468–475, 1999. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V. Bauchau and S.R. Durham, Prevalence and rate of diagnosis of allergic rhinitis in Europe, Eur. Respir. J., 24: 758–764, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H.J. Malling, Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: Methodological approaches and experimental results, Curr. Opin. Allergy Clin. Immunol., 4: 539–542, 2004. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• A.W. Wheeler and S.R. Woroniecki, Allergy vaccines—new approaches to an old concept, Expert Opin. Biol. Ther., 4: 1473–1481, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. Bousquet, R. Lockey, and H.J. Malling, Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper, J. Allergy Clin. Immunol., 102: 558–562, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T.B. Casale, Status of immunotherapy: Current and future, J. Allergy Clin. Immunol., 113: 1036–1039, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G. Passalacqua, L. Guerra, M. Pasquali, C. Lombardi, and G.W. Canonica, Efficacy and safety of sublingual immunotherapy, Ann. Allergy Asthma Immunol., 93: 3–12, quiz 12–13, 103, 2004. [CSA]
   PubMed Web of Science ®Google Scholar
• G.B. Gidaro, F. Marcucci, L. Sensi, C. Incorvaia, F. Frati, and G. Ciprandi, The safety of sublingual-swallow immunotherapy: An analysis of published studies, Clin. Exp. Allergy, 35: 565–571, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.M. Fellrath, A. Kettner, N. Dufour, C. Frigerio, D. Schneeberger, A. Leimgruber, G. Corradin, and F. Spertini, Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial, J. Allergy Clin. Immunol., 111: 854–861, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.B. Kay and M. Larche, Allergen immunotherapy with cat allergen peptides, Springer Semin. Immunopathol., 25: 391–399, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F. Kussebi, F. Karamloo, C. Rhyner, P. Schmid-Grendelmeier, M. Salagianni, C. Mannhart, M. Akdis, L. Soldatova, Z. Markovic-Housley, B.R., , et al., A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy, J. Allergy Clin. Immunol., 115: 323–329, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R. Valenta and D. Kraft, Recombinant allergen molecules: Tools to study effector cell activation, Immunol. Rev., 179: 119–127, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W.G. Degen, T. Jansen, and V.E. Schijns, Vaccine adjuvant technology: From mechanistic concepts to practical applications, Expert Rev. Vaccines, 2: 327–335, 2003. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• C. Rolinck-Werninghaus, E. Hamelmann, T. Keil, M. Kulig, K. Koetz, B. Gerstner, J. Kuehr, S. Zielen, U. Schauer, W. Kamin, , et al., The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children, Allergy, 59: 973–979, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L. Noon, Prophylactic inoculation against hay fever, Lancet, 1: 1572–1573, 1911. [CSA]
   Google Scholar
• J. Banchereau and R.M. Steinman, Dendritic cells and the control of immunity, Nature, 392: 245–252, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.S. Norman, Immunotherapy: 1999–2004, J. Allergy Clin. Immunol., 113: 1013–1023; quiz 1024, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K.J. Drachenberg, A.W. Wheeler, P. Stuebner, and F. Horak, A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections, Allergy, 56: 498–505, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• I. Maillard, S.H. Adler, and W.S. Pear, Notch and the immune system, Immunity, 19: 781–791, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R. Devos, G. Plaetinck, S. Cornelis, Y. Guisez, J. Van der Heyden, and J. Tavernier, Interleukin-5 and its receptor: A drug target for eosinophilia associated with chronic allergic disease, J. Leukoc. Biol., 57: 813–819, 1995. [CSA]
   PubMed Web of Science ®Google Scholar
• Committee on Safety of Medicines, Desensitizing vaccines, Br. Med. J., 293: 948, 1986. [CSA]
   PubMed Web of Science ®Google Scholar
• D.R. Wilson, M.T. Lima, and S.R. Durham, Sublingual immunotherapy for allergic rhinitis: Systematic review and meta-analysis, Allergy, 60: 4–12, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. Bousquet, P. Scheinmann, M.T. Guinnepain, M. Perrin-Fayolle, J. Sauvaget, A.B. Tonnel, G. Pauli, D. Caillaud, R. Dubost, F. Leynadier, , et al., Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study, Allergy, 54: 249–260, 1999. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D.B. Golden, Insect sting allergy and venom immunotherapy: A model and a mystery, J. Allergy Clin. Immunol., 115: 439–447; quiz 448, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H.J. Malling, J. Abreu-Nogueira, E. Alvarez-Cuesta, B. Bjorksten, J. Bousquet, D. Caillot, G.W. Canonica, G. Passalacqua, P. Saxonis-Papageorgiou, and E. Valovirta, Local immunotherapy, Allergy, 53: 933–944, 1998. [CSA]
   PubMed Web of Science ®Google Scholar
• H.S. Nelson, Advances in upper airway diseases and allergen immunotherapy, J. Allergy Clin. Immunol., 115: 676–684, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• F. Purello-D'Ambrosio, S. Gangemi, S. Isola, N. La Motta, P. Puccinelli, S. Parmiani, E. Savi, and L. Ricciardi, Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both, Allergy, 54: 968–973, 1999. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C. Lombardi, S. Gargioni, S. Venturi, P. Zoccali, G.W. Canonica, and G. Passalacqua, Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: Effect on bronchial hyperreactivity, J. Invest. Allergol. Clin. Immunol., 11: 41–45, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• C. Andre, M. Perrin-Fayolle, M. Grosclaude, P. Couturier, D. Basset, J. Cornillon, D. Piperno, B. Girodet, R. Sanchez, C. Vallon, , et al., A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship, Int. Arch. Allergy Immunol., 131: 111–118, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V. Di Rienzo, F. Marcucci, P. Puccinelli, S. Parmiani, F. Frati, L. Sensi, G.W. Canonica, and G. Passalacqua, Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: A 10-year prospective study, Clin. Exp. Allergy, 33: 206–210, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• U. Muller, C.A. Akdis, M. Fricker, M. Akdis, T. Blesken, F. Bettens, and K. Blaser, Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom, J. Allergy Clin. Immunol., 101: 747–754, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.S. Creticos, Y.H. Chen, and J.T. Schroeder, New approaches in immunotherapy: Allergen vaccination with immunostimulatory DNA, Immunol. Allergy Clin. North. Am., 24: 569–581, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.V. Kopp, J. Brauburger, F. Riedinger, D. Beischer, G. Ihorst, W. Kamin, S. Zielen, C. Bez, F. Friedrichs, A. Von Berg, , et al., The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis, J. Allergy Clin. Immunol., 110: 728–735, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar